NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


ADVERTISMENT

ADVERTISMENT

Biologics increase Covid-19 infection risk but may protect psoriatic patients from ICU hospitalisation and death — study

By Irish Pharmacist - 30th Nov 2020

Treatment with biologics increases the risk of Covid-19 infection in psoriatic patients but appears to protect them from ICU hospitalisation and death, according to the results from an Italian study revealed at the European Academy of Dermatology and Venereology (EADV) Congress, EADV Virtual.

The study compared 1,193 adult psoriatic patients receiving biologics and small molecules under the care of the San Donato Hospital in Milan, Italy, compared with the population of the Lombardy Region, Italy, from 21 February 2020 (first case of coronavirus in Italy) to 9 April 2020.

Compared with the general population of Lombardy, patients receiving biologics were at higher risk of testing positive for Covid-19 (unadjusted OR 3.43 [95%CI 2.25-5.73], p<0.0001), being self-quarantined at home (OR 9.05 [95%CI 5.61-14.61], p<0.0001) and being hospitalised (unadjusted OR 3.59 [95%CI 1.49-8.63], p=0.0044). However, their risk of being admitted to ICU (unadjusted OR 3.41 [95%CI 0.21-54.55], p=0.3861) and of dying (unadjusted OR 0.41 [95%CI 0.03-6.59], p=0.5306) were not statistically significant.

Dr Giovanni Damiani, a dermatologist at University of Milan, Clinical Dermatology, IRCCS Instituto Ortopedico Galeazzi, Italy, said: “Despite the higher risk for Covid-19 displayed by obese, active smokers and COPD patients, there were almost no data about the risk for psoriasis patients treated with biologics.

“Although biologics, since they suppress the immune system, increased patients’ risk of being infected with Covid-19 compared with the general population, we were pleasantly surprised to see that they did not increase their risk of severe disease and death.”

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist June 2024

Irish Pharmacist June 2024. Volume 25 | Issue 6 | June 2024. Read the latest issue of Irish Pharmacist here…

Read

OTC Update Spring 2024

Spring 2024 | Issue 1 | Volume 18. Read the latest issue of OTC Update here.

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT